Results of a Phase I/II study on a new diabetic neuropathy therapeutic drug were presented at the ‘BIO Korea 2011 Conference & Exhibition’ held in Seoul, Korea. ViroMed announced the possibility of an innovative treatment method completely different from currently available treatments. READ MORE
Source: BioSpace.com